Your shopping cart is currently empty

PRMT4-IN-1 is a selective inhibitor of PRMT4, demonstrating an IC50 value of 3.2 nM, and has been shown to reduce the relative viability of MCF7 cells [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,670 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $2,180 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,800 | 6-8 weeks | 6-8 weeks |
| Description | PRMT4-IN-1 is a selective inhibitor of PRMT4, demonstrating an IC50 value of 3.2 nM, and has been shown to reduce the relative viability of MCF7 cells [1]. |
| Targets&IC50 | PRMT8:1.95 μM, PRMT4:3.2 nM, PRMT7:1.68 μM, PRMT5:1.46 μM, PRMT3:4.05 μM, PRMT6:1.75 μM, PRMT1:0.835 μM |
| In vitro | PRMT4-IN-1 (compound 12h) at concentrations of 10 μM, 50 μM, and 100 μM did not affect the number of metabolically active cells after exposure durations of 24 hours and 72 hours [1]. A time-dependent decrease in relative cell viability was observed in MCF7 cells treated with PRMT4-IN-1 (50 μM) over a period of 2-8 days [1]. |
| Molecular Weight | 381.49 |
| Formula | C23H28FN3O |
| Cas No. | 912970-79-7 |
| Smiles | FC1=C(NC=2C1=CC(=CC2)C3CCN(CCNC)CC3)C4=C(OC)C=CC=C4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.